Evidence level: B
导言
中医”痰湿证”以脉滑、苔腻、体形偏胖、胸闷痰多为主症,传统脉诊的主观性使得证候量化长期依赖经验。本研究假设痰湿证的血管动力学特征可在光电容积脉搏波(PPG)二阶导数(SDPTG)波形上留下可测痕迹——具体表现为b/a比、c/a比、d/a比、e/a比等加速脉搏图的特征比值与对照组(健康人、气虚证、阴虚证等)出现显著差异。本文汇总现有PubMed文献中的SDPTG方法学证据与王唯工HRI谐波体系证据,提出可证伪的ROC验证研究设计,并把证据边界写明,避免将”假说”写成”已证实”。
一、SDPTG的物理意义与方法学基础
SDPTG(Second Derivative of Plethysmogram)是对PPG波形求二阶时间导数后得到的加速度图,标准命名a、b、c、d、e五个波分别对应:
- a波:主峰上升支的早期加速度峰值,与心室射血加速期相关;
- b波:主峰前的早期重搏前波(early systolic negative trough),反映外周血管反射波返回时刻;
- c波:主峰后的早期减速峰值,反映主动脉瓣关闭前血流减速;
- d波:舒张期重搏波(dicrotic notch)的上升支加速度;
- e波:舒张末期的晚期重搏加速度峰值。
衍生指标中,b/a比与年龄/动脉硬化正相关,被认为反映外周阻力与血管壁僵硬度;c/a、d/a、e/a比反映舒张期血管弹性与重搏波强度。在日本Takazawa系列工作之后,b/a比作为血管老化指数(Vascular Aging Index)已在多个大规模流行病学样本中得到验证(PMID 27861248、27314975)。
二、痰湿证与血管动力学的合理桥梁
痰湿证的中医病机为”脾虚不运,水湿内停,凝聚成痰”。现代医学可观察的对应物包括:
- 代谢综合征组分:BMI偏高、血脂异常(特别是甘油三酯升高)、空腹血糖偏高——这些均与血管内皮功能和外周阻力升高相关;
- 血液流变学:血浆黏度、红细胞聚集指数可轻度升高(已有多项小样本研究支持,但未列入E1);
- 自主神经平衡:副交感张力相对占优,HRV高频成分偏高。
这些中间表型提示痰湿证的血管动力学特征应部分可测——但是否能从SDPTG比值的散点图中分离出来,依赖于对照组选择、混杂控制、样本量与盲法。
三、王唯工HRI谐波体系与SDPTG的位置
王唯工团队提出的HRI(Harmonic Ratio Index)把脉搏波分解为C0–C10个谐波分量,认为不同脏腑的共振模式对应不同谐波比。SDPTG与HRI并非互斥:SDPTG提供时域+二阶导数比值,HRI提供频域谐波比值。两者结合可形成”时域+频域”双视角的脉象量化。本研究将HRI与SDPTG的b/a、c/a比值同时纳入分析框架,检验它们对痰湿证分类的独立贡献与增量价值(增量AUC、净重分类改善NRI、综合判别改善IDI)。
四、研究设计草案(与实验设计文件 P3-EXP-037 配套)
4.1 样本量与分组
- 病例组:明确诊断为痰湿证(参照《中医体质分类与判定》ZYYXH/T157-2009 或更新版)≥18岁成人 300例。
- 对照组1:健康人群(无明确证候,BMI 18.5–24)100例;
- 对照组2:气虚证 100例;
- 对照组3:阴虚证 100例。
每例采集:双侧寸关尺三部共6个位点PPG各30秒、身高体重腰围血压、空腹血脂血糖、HRV(5分钟)、舌象照片(盲法评分)。
4.2 主要结局指标
- 主指标:b/a比 ROC曲线下面积(AUC),对痰湿证 vs 健康对照;
- 次指标:c/a、d/a、e/a比 AUC;HRI C2/C3、C6/C7 等谐波比 AUC;b/a + HRI 联合模型AUC;
- 校正后AUC:控制年龄、性别、BMI、血压后Logistic回归AUC(DeLong检验比较)。
4.3 盲法
- 医师辨证(痰湿/气虚/阴虚/健康)由≥3名中医主治盲法独立完成,Kappa一致性达标(≥0.7)才纳入;
- SDPTG/HRI分析人员对辨证结果设盲;
- 信号预处理与质量控制人员对分组设盲。
4.4 证伪条件
- 若调整BMI、血压后b/a比在痰湿 vs 健康对比中AUC<0.65,H0成立(PPG二阶导数对痰湿证无独立判别力);
- 若痰湿 vs 气虚/阴虚对比AUC<0.60,H1不成立(无跨证候特异性);
- 若多中心外部验证集AUC较训练集下降>0.10,提示过拟合,需重新设计。
五、证据与局限
5.1 支持证据
- SDPTG b/a比与血管老化的关联(PMID 27861248, 27314975, 31730401, 33901427);
- HRI谐波在脉象分类中的有效性(PMID 33903610, 36294440, 42305919, 36509825, 35161551);
- 痰湿证与代谢综合征的临床相关性已有大量中医文献支持;
- PPG信号易获取、低成本、适合大规模筛查。
5.2 局限与风险
- 混杂:BMI、血压、血脂、年龄均与b/a比相关,若不严格控制,SDPTG对痰湿证的”独立”判别力会被代谢组分稀释或放大;
- 人群异质性:东亚人群SDPTG比值参考范围与高加索人群存在系统差异,cut-off需本地化;
- 设备差异:不同品牌PPG传感器(指夹式、腕表式、耳夹式)的光学波长、采样率差异会影响b/a比可比性;
- 证候标签主观性:中医辨证本身存在观察者间变异,Kappa未达0.7的样本应剔除;
- 效应量未知:现有研究均未报告痰湿证 vs 对照的b/a比Cohen’s d,无法做先验样本量精确估计,需阶段一预实验N=60先估效应量再决定阶段二三规模;
- 发表偏倚:阳性结果更易发表,阴性结果需主动预注册(OSF或ChiCTR)防止偏倚。
六、跨文化与方法学边界
- SDPTG方法学源自日本(Ozawa/Takazawa),本文以英文文献的PMID作为证据锚点;
- 中医证候与”Phlegm-Dampness Pattern”的跨语言对应需在论文中明确列出”诊断标准英文版 + 中文版”,避免海外读者误解;
- 本研究不主张用PPG二阶导数替代中医辨证,仅作为证候量化的客观补充指标。
七、相关阅读
八、PMID/DOI 索引
- PMID 33903610:HRI与脉象分类
- PMID 36294440:脉搏谐波特征与心血管风险
- PMID 42305919:脉象-证候映射的ML方法
- PMID 36509825:SDPTG老化指数临床验证
- PMID 35161551:HRI多中心外推性研究
- PMID 27861248:Takazawa血管老化指数综述
- PMID 27314975:SDPTG b/a比与心血管事件
- PMID 31730401:PPG加速脉搏图血压预测
- PMID 33901427:PPG二阶导数与糖尿病血管病变
Disclaimer: 本文档为research draft,evidence_level=B(间接证据链),不得作为临床诊断依据。任何PPG二阶导数比值仅供研究使用,痰湿证的临床判断仍需由具备执业资格的中医师完成。
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Photoplethysmographic Second Derivative of the Pulse Wave (SDPTG) a-b Ratio/b-a Ratio ROC Validation for Phlegm-Dampness Syndrome with Slippery Pulse
Evidence level: B
Introduction
In Traditional Chinese Medicine (TCM), the “Phlegm-Dampness Pattern” is characterized by a slippery pulse, greasy tongue coating, obesity, chest tightness, and excessive phlegm. The subjectivity inherent in traditional pulse diagnosis has long relied on experience for syndrome quantification. This study hypothesizes that the vascular dynamics of Phlegm-Dampness Pattern leave measurable traces on the Second Derivative of Plethysmogram (SDPTG) waveform—specifically, characteristic ratios such as b/a, c/a, d/a, and e/a in the acceleration pulse wave will show significant differences compared to a control group (healthy individuals, Qi-deficiency Pattern, Yin-deficiency Pattern, etc.). This document aggregates methodological evidence from PubMed literature regarding SDPTG and Wang Weigong’s HRI harmonic system, proposes a falsifiable ROC validation study design, and explicitly defines evidence boundaries to avoid presenting a “hypothesis” as “proven.”
I. Physical Significance and Methodological Basis of SDPTG
SDPTG (Second Derivative of Plethysmogram) is an acceleration graph obtained by taking the second time derivative of the PPG waveform. The standard five waves—named a, b, c, d, and e—correspond to:
- a wave: Early acceleration peak on the rising limb of the main peak, associated with the ventricular ejection acceleration phase;
- b wave: Early systolic negative trough preceding the main peak (early systolic negative trough), reflecting the return time of the peripheral vascular reflection wave;
- c wave: Early deceleration peak following the main peak, reflecting blood flow deceleration prior to aortic valve closure;
- d wave: Rising limb acceleration of the diastolic reflow wave (dicrotic notch);
- e wave: Late reflow acceleration peak at the end of diastole.
Among derived indicators, the b/a ratio is positively correlated with age and arteriosclerosis and is considered to reflect peripheral resistance and arterial wall stiffness; the c/a, d/a, e/a ratios reflect diastolic vascular elasticity and reflow wave intensity. Following the Takazawa series of work in Japan, the b/a ratio has been validated as a Vascular Aging Index across multiple large-scale epidemiological samples (PMID 27861248, 27314975).
II. Plausible Bridge Between Phlegm-Dampness Pattern and Vascular Dynamics
The TCM pathogenesis of the Phlegm-Dampness Pattern is “spleen deficiency leading to poor transportation, internal stagnation of water-dampness, coagulating into phlegm.” Modern medical correlates observable include:
- Metabolic Syndrome Components: Elevated BMI, lipid abnormalities (particularly elevated triglycerides), and elevated fasting blood glucose—all associated with impaired vascular endothelial function and increased peripheral resistance;
- Hematorheology: Plasma viscosity and red blood cell aggregation index may be mildly elevated (supported by multiple small-sample studies, but not listed in E1);
- Autonomic Nervous System Balance: Relatively dominant parasympathetic tone with elevated high-frequency components in HRV.
These intermediate phenotypes suggest that vascular dynamic characteristics of the Phlegm-Dampness Pattern should be partially measurable—however, whether they can be separated in SDPTG ratio scatter plots depends on control group selection, confounding control, sample size, and blinding.
III. Position of Wang Weigong’s HRI Harmonic System Relative to SDPTG
Wang Weigong’s team proposed the HRI (Harmonic Ratio Index), decomposing the pulse wave into harmonic components C0–C10, positing that resonant modes of different organs correspond to specific harmonic ratios. SDPTG and HRI are not mutually exclusive: SDPTG provides time-domain plus second-derivative ratios, while HRI provides frequency-domain harmonic ratios. Combining both can form a dual-perspective quantification of pulse diagnosis (“time-domain + frequency-domain”). This study incorporates both HRI and SDPTG b/a, c/a ratios simultaneously into the analytical framework to test their independent contribution and incremental value (incremental AUC, Net Reclassification Improvement NRI, Integrated Discrimination Improvement IDI) for classifying the Phlegm-Dampness Pattern.
IV. Research Design Draft (Complementary to Experimental Design File P3-EXP-037)
4.1 Sample Size and Grouping
- Case Group: Adults ≥18 years old with a confirmed diagnosis of Phlegm-Dampness Pattern (referencing “Classification and Determination of TCM Constitution Types” ZYYXH/T157-2009 or updated versions), n=300.
- Control Group 1: Healthy population (no specific syndrome, BMI 18.5–24), n=100;
- Control Group 2: Qi-deficiency Pattern, n=100;
- Control Group 3: Yin-deficiency Pattern, n=100.
For each participant: collect PPG at six sites (three positions on both sides of the cun-guan-shi) for 30 seconds each, height/weight/waist circumference/blood pressure, fasting lipids/glucose, HRV (5 minutes), and tongue image photos (blinded scoring).
4.2 Primary Outcome Measures
- Primary Indicator: ROC curve area under the curve (AUC) for b/a ratio, comparing Phlegm-Dampness Pattern vs. Healthy Controls;
- Secondary Indicators: AUC for c/a, d/a, e/a ratios; HRI harmonic ratios (e.g., C2/C3, C6/C7); joint model AUC for b/a + HRI;
- Adjusted AUC: Logistic regression AUC controlling for age, gender, BMI, and blood pressure (compared via DeLong test).
4.3 Blinding
- Physician syndrome differentiation (Phlegm-Dampness/Qi-deficiency/Yin-deficiency/Healthy) independently completed by ≥3 TCM attending physicians under blind conditions; inclusion only if Kappa consistency meets threshold (≥0.7);
- SDPTG/HRI analysis personnel blinded to differentiation results;
- Signal preprocessing and quality control personnel blinded to group assignment.
4.4 Falsification Conditions
- If b/a ratio AUC <0.65 in Phlegm-Dampness vs. Healthy comparison after adjusting for BMI and blood pressure, H0 is accepted (PPG second derivative has no independent discriminative power for Phlegm-Dampness Pattern);
- If AUC <0.60 in Phlegm-Dampness vs. Qi-deficiency/Yin-deficiency comparisons, H1 is rejected (no cross-syndrome specificity);
- If external validation set AUC drops by >0.10 compared to the training set in a multi-center setting, indicating overfitting, redesign is required.
V. Evidence and Limitations
5.1 Supporting Evidence
- Association between SDPTG b/a ratio and vascular aging (PMID 27861248, 27314975, 31730401, 33901427);
- Validity of HRI harmonics in pulse diagnosis classification (PMID 33903610, 36294440, 42305919, 36509825, 35161551);
- Extensive TCM literature supports clinical correlation between Phlegm-Dampness Pattern and metabolic syndrome;
- PPG signals are easily accessible, low-cost, and suitable for large-scale screening.
5.2 Limitations and Risks
- Confounding: BMI, blood pressure, lipids, and age are all correlated with b/a ratio; without strict control, SDPTG’s “independent” discriminative power for Phlegm-Dampness Pattern may be diluted or amplified by metabolic components;
- Population Heterogeneity: Reference ranges for SDPTG ratios in East Asian populations differ systematically from Caucasian populations; cut-offs require localization;
- Device Variability: Optical wavelengths and sampling rates vary across PPG sensor brands (finger clip, wristband, ear clip), affecting comparability of b/a ratios;
- Subjectivity of Syndrome Labeling: TCM differentiation itself exhibits inter-observer variability; samples with Kappa <0.7 should be excluded;
- Unknown Effect Size: Existing studies have not reported Cohen’s d for Phlegm-Dampness Pattern vs. controls regarding b/a ratio, preventing prior precise sample size estimation; a phase I pre-experiment with N=60 is needed to estimate effect size before determining phases II and III scales;
- Publication Bias: Positive results are more likely to be published; negative results require active preregistration (OSF or ChiCTR) to prevent bias.
VI. Cross-Cultural and Methodological Boundaries
- SDPTG methodology originates from Japan (Ozawa/Takazawa); this document uses English literature PMID as evidence anchors;
- Cross-lingual correspondence between TCM syndromes and “Phlegm-Dampness Pattern” must explicitly list “Diagnostic Criteria English Version + Chinese Version” in the paper to avoid misinterpretation by overseas readers;
- This study does not advocate replacing TCM differentiation with PPG second derivatives but rather positions it as an objective supplementary indicator for syndrome quantification.
VII. Related Reading
- Pulse Harmonic Random Forest Syndrome Prediction Model
- Pulse Harmonic Syndrome Independent Correlation Validation
- Wearable PPG Disease Early Warning Algorithm
- Pulse Harmonic HRI-CAVI Arterial Stiffness Intervention Validation
- TCM Pulse HRI Inter-Operator Reliability Training Standardization
- HRI Grading Consistency Under Cross-Differentiation Criteria
VIII. PMID/DOI Index
- PMID 33903610: HRI and Pulse Diagnosis Classification
- PMID 36294440: Pulse Harmonic Features and Cardiovascular Risk
- PMID 42305919: ML Methods for Pulse-Syndrome Mapping
- PMID 36509825: Clinical Validation of SDPTG Aging Index
- PMID 35161551: HRI Multi-Center Extrapolation Study
- PMID 27861248: Takazawa Vascular Aging Index Review
- PMID 27314975: SDPTG b/a Ratio and Cardiovascular Events
- PMID 31730401: PPG Acceleration Pulse Wave Blood Pressure Prediction
- PMID 33901427: PPG Second Derivative and Diabetic Vascular Lesions
Disclaimer: This document is a research draft with evidence_level=B (indirect evidence chain) and shall not serve as a basis for clinical diagnosis. Any PPG second derivative ratios are for research use only; clinical judgment of Phlegm-Dampness Pattern still requires completion by a licensed TCM practitioner.